Bristol-Myers Squibb (BMY)

Bristol-Myers Squibb

BMY

#186

Rank

£91.14 B

Marketcap

🇺🇸 United States

Country

£44.62

Share price

-0.77%

Change (1 day)

36.66%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Bristol-Myers Squibb - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year	P/B ratio	Change
2026-12-31	N/A	-100%
2025-12-31	5.88	-17.62%
2024-12-31	7.14	101.6%
2023-12-31	3.54	-27.97%
2022-12-31	4.92	27.9%
2021-12-31	3.84	3.88%
2020-12-31	3.70	33.76%
2019-12-31	2.77	-53.7%
2018-12-31	5.98	-29.42%
2017-12-31	8.47	41.7%
2016-12-31	5.97	-24.58%
2015-12-31	7.92	21.64%
2014-12-31	6.51	13.76%
2013-12-31	5.72	46.97%
2012-12-31	3.90	3.5%
2011-12-31	3.76	30.82%
2010-12-31	2.88	-1.43%
2009-12-31	2.92	-22.59%
2008-12-31	3.77	-23.94%
2007-12-31	4.96	-4.1%
2006-12-31	5.17	28.81%
2005-12-31	4.01	-17.94%
2004-12-31	4.89	-13.76%
2003-12-31	5.67	9.77%
2002-12-31	5.17

P/B ratio for similar companies or competitors

Company	P/B ratio	P/B ratio differencediff.	Country
Johnson & Johnson JNJ	7.41	37.04%	🇺🇸 USA
Novartis NVS	6.51	20.38%	🇨🇭 Switzerland
Pfizer PFE	1.89	-65.16%	🇺🇸 USA
AbbVie ABBV	-83.0	-1,633.48%	🇺🇸 USA
Eli Lilly LLY	31.0	473.41%	🇺🇸 USA
Amgen AMGN	19.2	254.65%	🇺🇸 USA
Sanofi SNY	1.21	-77.65%	🇫🇷 France
Biogen BIIB	1.77	-67.30%	🇺🇸 USA
Merck MRK	8.56	58.13%	🇺🇸 USA
AstraZeneca AZN	4.90	-9.41%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Bristol-Myers Squibb (BMY) - P/B ratio

P/B ratio as of October 2026 : 5.41